Stryker announces planned leadership change: Lobo to become executive chair, Stiles new CEO
Stryker Corporation said Kevin A. Lobo will resign as chief executive officer on Dec. 31, 2026 and will become executive chair of the board on Jan. 1, 2027, while current president and chief operating officer Spencer S. Stiles will become the new chief executive officer and president.
Key points
- In a press release on Oct.
- Stiles' appointment is confirmed by a letter agreement signed Oct.
- Keeping Lobo's current compensation and his successful leadership that grew net sales from $8.7 billion in 2012 to more than $26 billion in 2026 and completed over 60 acquisitions, including Mako, creates a basis for steady growth if the new CEO can maintain strategic continuity.
What happened
In a press release on Oct. 6, 2026, Stryker announced that Kevin Lobo will leave the CEO role on Dec. 31, 2026 and become executive chair of the board on Jan. 1, 2027, and that Spencer Stiles, the current president and chief operating officer, will be appointed CEO and president effective Jan. 1, 2027.
Why it matters
Stiles' appointment is confirmed by a letter agreement signed Oct. 5, 2026, and his experience includes serving as president and COO since Jan. 2026, previously group president of orthopaedics from 2019, and a 27‑year career at Stryker with leadership roles in orthopaedics, MedSurg, Neurotechnology and international regions.
When it could benefit investors
Keeping Lobo's current compensation and his successful leadership that grew net sales from $8.7 billion in 2012 to more than $26 billion in 2026 and completed over 60 acquisitions, including Mako, creates a basis for steady growth if the new CEO can maintain strategic continuity.
Risks and uncertainties
The leadership transition could disrupt operating momentum, as Lobo’s successes – triple‑digit sales growth and over 60 acquisitions – stemmed from his long‑term strategy. If Stiles cannot sustain this pace, the company could lose growth momentum.
What to watch
Watch the first 2027 financial results, especially sales and new acquisitions, and board statements on executive chair Lobo’s performance.
Original sources
- 8-K filing, October 6, 2026
- 8-K EX-99.1 filing, October 6, 2026
- 8-K EX-10.1 filing, October 6, 2026
- 8-K EX-10.2 filing, October 6, 2026
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Stryker
A notification in your browser or on your phone when we publish about Stryker. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
